Advertisement

Reactions Weekly

, Volume 1733, Issue 1, pp 121–121 | Cite as

Crizotinib

Development of drug resistance in non-small cell lung cancer: case report
Case report
  • 11 Downloads

Reference

  1. Berger L-A, et al. Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib. Journal of Thoracic Oncology 13: e243-e246, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.08.2025 -GermanyCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations